04.04.26 -- Clinical Supply Leader Best Of March

FDA staffing shortages and supply pressures are reshaping clinical trials, requiring closer coordination across regulatory, manufacturing, and operations.

Global shifts are rewriting the rules of clinical supply. Rising costs, regional regulations, and material scarcity mean planners must rethink strategies or risk costly disruptions.

Clinical supply risk often begins long before manufacturing or distribution. Flawed demand signals and enrollment forecasts can quietly create shortages, delays, and costly material waste.

The hidden factors behind capsule‑filling accuracy: materials, dosing approaches, and equipment choices that make or break precision.

By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

Transform supply chain management by integrating technology solutions and real-time insights to link patient-level data with upstream manufacturing operations.